Stockwinners Market Radar for August 03, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:18 EDT Inozyme director buys $4.0M in common stock - In a regulatory filing, Inozyme disclosed that its director Robert Hopfner bought 833K shares of common stock on August 1st in a total transaction size of $4.0M.

20:13 EDT Mesoblast receives complete response from FDA to BLA for remestemcel-L - Mesoblast "announced that the FDA has provided a complete response to its Biologics License Application resubmission for remestemcel-L for the treatment of pediatric steroid-refractory acute graft versus host disease and requires more data to support marketing approval. To obtain the data required, Mesoblast will conduct a targeted, controlled study in the highest-risk adults with the greatest mortality. This adult study is in line with our overall commercial strategy, which envisioned a sequenced progression from pediatric to adult SR-aGVHD indications. Adults comprise 80% of the SR-aGVHD market. Mesoblast intends to enroll adult patients at highest mortality risk with SR-aGVHD where existing therapy has not improved outcomes and 90-day survival remains as low as 20-30%.1 Mesoblast has generated pilot data through its emergency IND program in adults showing a survival benefit with remestemcel-L in this target population. In line with our overall commercial strategy to expand into the adult SR-aGVHD indication, Mesoblast has already been working with leading investigators at various US centers of excellence to establish the adult follow-on study protocol, potentially utilizing established clinical trials networks. The company will seek alignment with FDA on the trial design for the adult study at a Type A meeting within 45 days." CEO Silviu Itescu said: "FDA's inspection of our manufacturing process resulted in no observed concerns, the Agency raised no safety issues across more than 1300 patients who have received remestemcel-L to date, and acknowledged improvements to our potency assay. We remain steadfast in making remestemcel-L available to both children and adults suffering from this devastating disease, and have received substantial clarity in how to bring this much-needed product to these patients".

20:06 EDT Cathie Wood's ARK Investment bought 383.8K shares of Adaptive Biotechnologies

19:01 EDT Avista reaches all-party, all-issues settlement in Oregon general rate case - Avista, the Staff of the Public Utility Commission of Oregon, the Oregon Citizens' Utility Board, Alliance of Western Energy Consumers, and the joint intervenor Sierra Club/Climate Solutions, parties to the Company's natural gas general rate case, have reached a settlement agreement that has been submitted to the Commission for its consideration, and which would resolve all remaining issues in the proceeding. If approved, this settlement would result in a base revenue increase request of $7.16 million (or 4.7%), as compared to Avista's original request of $11.0 million. The agreed-upon revenue requirement is predicated on a proposed rate of return of 7.235% with a common equity ratio of 50% and a 9.5% return on equity. "This settlement agreement will provide new rates in Oregon that are fair and reasonable for our customers, the Company, and our shareholders," said Dennis Vermillion, Avista president and CEO. "This outcome allows us to recover our costs in a timely manner and supports Avista's efforts to invest in and maintain our infrastructure so we can continue to provide the reliable energy our customers expect."

18:46 EDT Clorox CEO: The wipes business continues to grow for us - In an interview on CNBC's Mad Money, Linda Rendle said investors should continue to look for innovations across all of Clorox's products. Kingsford has not performed to the company's expectations, she noted.

18:22 EDT Tesla exec Zhu sells 2,500 common shares - In a regulatory filing, Tesla senior VP of Automotive Xiaotong Zhu disclosed the sale of 2,500 common shares of the company on August 1 at a price of $266.34 per share.

18:04 EDT LGI Homes announces 587 home closings in July - LGI Homes "announced it closed 587 homes in July 2023. As of July 31, 2023, the Company had 103 active selling communities."

17:53 EDT Amazon 'encouraged' by strength in reported revenue in Q2 - Says continues to see healthy demand across essentials. Says working capital hasn't been as efficient over past couple of years. Says remains focused on continued free cash flow improvement going forward.

17:43 EDT El Pollo Loco sees FY23 capex at $22M-$25M - In FY23, the company plans to open two new company-owned restaurants and three to four new franchised restaurants.

17:32 EDT Apple says continues to take 'deliberate' actions to manage spend - Says iPhone reached all-time revenue record in India in Q3. "Very pleased" with Services performance in Q3.

17:26 EDT Boeing VP Colbert sells over $2M in company shares - VP of Boeing Theodore Colbert disclosed the sale of 8,500 shares of company stock at $238.37 per share on August 1 for a total transaction amount of $2,026,137.

17:23 EDT Dropbox backs long-term target of 80%-82% in gross margins - Backs 30%-32% operating margin and $1B in free cash flow by 2024. Comments taken from investor presentation slides.

17:16 EDT Terns Pharmaceuticals CEO Senthil Sundaram resigns, Erin Quirk succeeds - Terns Pharmaceuticals announced that Senthil Sundaram has resigned from his position as Terns' Chief Executive Officer for health reasons previously disclosed in January 2022. Sundaram also resigned from the Board of Directors of Terns but will remain on as a Senior Advisor to the Company. Erin Quirk, M.D., President and Head of Research & Development at Terns, will assume leadership of the Company, effective immediately. "On behalf of the entire Board, I extend our gratitude to Sen for his many contributions to Terns during his CEO tenure. Sen played an important role in the Company's buildout, including the expansion and diversification of our pipeline and the execution of our successful Initial Public Offering and subsequent sizeable fundraises that secured our financial foundation, all of which will propel Terns through to key growth inflection points. We wish all the best for Sen and his family and will always consider him a member of the Terns team," said David Fellows, Chairman of the Board of Terns. "Erin has been an integral member of Terns' executive leadership for more than four years and has been a valuable asset to the team as we have advanced our clinical programs in oncology and metabolic diseases. She is well suited to lead Terns through this transition."

17:13 EDT Dover increases quarterly dividend 0.5c to 51c per share - Dover increased its quarterly cash dividend to 51c per share, from the previous 50.5c per share, an increase of 0.5c. This increased dividend will be paid on September 15, 2023, to shareholders of record as of August 31, 2023.

17:06 EDT DraftKings jumps 10% to $33.10 after Q2 earnings beat, guidance raise

17:03 EDT Atlassian sees Fy24 cloud revenue up 25%-30% - In FY24, Cloud revenue growth year-over-year is expected to be in the range of 25% to 30%. Gross margin is expected to be approximately 81.0% on a GAAP basis and approximately 83.5% on a non-GAAP basis. Operating margin is expected to be approximately (8.0%) on a GAAP basis and approximately 18.5% on a non-GAAP basis.

17:02 EDT Microchip raises quarterly dividend to 41c per share - Microchip announced that its board of directors declared a quarterly cash dividend on its common stock of 41c per share. The dividend is payable on September 5 to stockholders of record on August 22. Microchip initiated quarterly cash dividend payments in the third quarter of fiscal year 2003 and has increased its dividend 78 times since its inception.

16:59 EDT Tupperware Brands announces debt restructuring - Tupperware Brands has finalized an agreement with its lenders to restructure its existing debt obligations, improving the Company's overall financial position by amending certain credit obligations and extending the maturity of certain debt facilities to allow it to continue with its turnaround efforts. This agreement is a comprehensive restructuring and reallocation of the company's debt and provides for, among other things: the reduction / reallocation of approximately $150M of cash interest and fees; the extension of the stated maturity of approximately $348M of principal and reallocated interest and fees to fiscal year 2027 with PIK interest; the reduction of amortization payments required to be paid through fiscal year 2025 by approximately $55M, and Immediate access to revolving borrowing capacity of approximately $21M.

16:56 EDT Werner raises capex view to $400M-$450M from $350M-$400M - The company is citing "greater pace of refreshing the fleet to reduce average equipment age." Werner also lowers fleet size count to down 4% to down 2% from down 2% to up 1% "to adapt to softer freight market".

16:56 EDT Booking Holdings says room nights up 20% year-over-year in July - Booking Holdings CFO said on the Q2 call: "In July, we saw year-over-year room night growth of about 20%, up from 9% in Q2. Looking across our major regions in July, we saw Asia up about 45%; rest of World, up over 20%; Europe up mid-teens; and the U.S. up mid-single digits. When comparing versus 2019, July room night growth was in a similar range to the 26% growth in Q2. The U.S. was our most recovered region with growth at over 30% versus 2019. Our comments for the third quarter made the assumption that room night growth will be up low double digits year-on-year, assuming some moderation in growth from July due in part to harder prior year comparables in August and September. You'll recall from our commentary on the third quarter of 2022, that room night growth versus 2019 was 4% in July 2022 and 10% in August and September 2022. In addition, we expect that due to expanded booking window in the first half of the year stayed in Q3, but there will be fewer last-minute bookings for stays in the rest of Q3. We expect Q3 gross bookings to grow about 7 points faster the room nights on a year-on-year basis due to a few points from continued flight bookings growth and a few points of positive impact from FX movements. We expect accommodation constant currency ADRs to be about in line with Q3 2022, including a couple of points of pressure from the changes in regional mix. We expect Q3 revenue as a percentage of gross bookings to be around 19%, slightly above last year due to a more positive impact from timing in part due to the expanded booking window in the first half of this year, and from increased revenue from payments. We expect we expect these will be partially offset by a higher mix of flights and increased merchandising spend, some of which is related to bookings we received earlier in the year."

16:49 EDT Coinbase maintains goal to improve FY23 adjusted EBITDA vs FY22 - The company said, "In July, we generated approximately $110 million of transaction revenue. We expect Q3 subscription and services revenue to be at least $300 million and Q3 transaction expenses as a percentage of net revenue to be in the mid teens. We anticipate Q3 technology & development and general & administrative expenses to be $575-625 million, with the Q/Q increase primarily driven by the timing of recognition of stock-based compensation expenses. We expect sales & marketing expenses to be $80-90 million. Lastly, we maintain our goal to improve full-year 2023 Adjusted EBITDA in absolute dollar terms versus fullyear 2022."

16:42 EDT Atlassian announces departure of CRO - Atlassian announced that its Chief Revenue Officer, CRO, Cameron Deatsch, will leave Atlassian at the end of December 2023. Cameron joined Atlassian almost 11 years ago, and during that time has built out its customer-facing teams, served as Head of Server & Data Center product teams, and led Atlassian's go-to-market functions as Chief Revenue Officer over the past three years.

16:37 EDT Deciphera announces retirement of CSO Flynn - Deciphera Pharmaceuticals announced that the Company's Founder, Executive Vice President, and Chief Scientific Officer, Daniel L. Flynn, Ph.D., will retire effective September 5, 2023 and will transition to a role as Senior Advisor to the Company. Dashyant Dhanak, Ph.D., has been appointed Executive Vice President and Chief Scientific Officer effective September 5, 2023. Dr. Dhanak brings over 30 years of experience in pharmaceutical research and development and joins Deciphera from Incyte Corporation where he was Executive Vice President and Chief Scientific Officer. "On behalf of all my colleagues, I want to thank Dan for his vision to found Deciphera two decades ago as a company dedicated to improving the lives of people with cancer. It has been an honor to work alongside such a trailblazing researcher whose innovations in drug discovery now benefit thousands of cancer patients around the world and have the potential to continue making an impact for years to come thanks to our rich clinical and pre-clinical pipeline developed from the research engine that Dan created," said Steve Hoerter, President and Chief Executive Officer of Deciphera Pharmaceuticals. "We are excited to build on our track record of innovation in drug discovery with the announcement that Dash Dhanak is joining Deciphera as our new Chief Scientific Officer. In addition to broad experience in drug discovery and development, Dash is a proven leader with a track record of advancing innovative oncology agents to the clinic. I look forward to working with Dash to continue to build a strong pipeline of novel therapies at Deciphera."

16:35 EDT Apple CEO highlights record Services revenue, over 1B paid subscriptions - Apple CEO Tim Cook said in the Q3 earnings release, "We are happy to report that we had an all-time revenue record in Services during the June quarter, driven by over 1 billion paid subscriptions, and we saw continued strength in emerging markets thanks to robust sales of iPhone. From education to the environment, we are continuing to advance our values, while championing innovation that enriches the lives of our customers and leaves the world better than we found it. Added CFO Luca Maestri, "Our June quarter year-over-year business performance improved from the March quarter, and our installed base of active devices reached an all-time high in every geographic segment. During the quarter, we generated very strong operating cash flow of $26 billion, returned over $24 billion to our shareholders, and continued to invest in our long-term growth plans."

16:33 EDT Apple reports Q3 Services revenue $21.21B vs. $19.60B last year

16:32 EDT Apple reports Q3 iPad revenue $5.79B vs. $8.08B last year

16:32 EDT Apple reports Q3 iPhone revenue $39.67B vs. $40.67B last year

16:29 EDT Carlisle raises quarterly dividend to 85c from 75c per share - The dividend is payable on September 1, 2023, to shareholders of record at the close of business on August 17, 2023.

16:24 EDT Southwestern Energy sees Q3 total production 419-439 Bcfe

16:23 EDT Resideo authorizes $150M share repurchase program - Resideo Technologies announced that its board of directors has approved a stock repurchase program, pursuant to which the company is authorized to purchase up to $150M of its common stock over an unlimited time period.

16:22 EDT Cue Health awarded $28M federal contract - Cue Health announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services (HHS), to develop a Flu A/B, RSV, and COVID-19 molecular multiplex test for both over-the-counter (OTC) and point-of-care (POC) use. Cue's test would detect and differentiate between influenza A, influenza B, respiratory syncytial virus (RSV), and COVID-19 simultaneously, with results delivered in approximately 25 minutes to connected smart devices. The company has also applied with the U.S. FDA for Emergency Use Authorization (EUA) for its Cue Flu + COVID-19 Molecular Test for at-home and point-of-care (POC) use. Cue also requested De Novo classification from the FDA for the Cue RSV Molecular Test for at-home and point-of-care use. In March, the company received an EUA from the FDA for the Cue Mpox (Monkeypox) Molecular Test, which can be performed at the point-of-care at any CLIA-waived facility.

16:17 EDT Trinseo sees FY23 adjusted EBITDA $215M - Commenting on the outlook for 2023, Bozich said, "Our forecast assumes a similar, constrained demand environment though the remainder of the year and we anticipate second half performance to be similar to the second quarter runrate. Despite the economic environment, we continue to improve our cash and liquidity profile, including working capital reductions and capital expenditure deferments. In addition, refinancing our near-term debt maturities is one of our highest priorities, and we are confident we'll be able to accomplish that in the third quarter."

16:15 EDT Fuel Tech awarded air pollution control orders totaling $2.2M - Fuel Tech, Inc. announced the receipt of multiple air pollution control (APC) contracts from new and existing customers in the US and Europe. These awards support projects serving various end markets and have an aggregate value of approximately $2.2 million. A contract was received from an industrial customer in the Midwest for a NOxOUT Selective Non-Catalytic Reduction (SNCR) system. Fuel Tech's SNCR technology is a proven solution for utility and industrial combustion unit owners looking to comply with more stringent NOx control requirements. Equipment delivery is expected in the fourth quarter of 2023. A second US order was received to upgrade an existing SNCR system on a coal-fired unit in the Midwest to comply with current and future NOx reduction requirements driven by the EPA creating a final rule as a next phase of the Cross State Air Pollution Rule to meet the Good Neighbor provision of the Clean Air Act. Delivery of the upgrade will be completed in the third quarter of 2023. An order was received from an existing US customer for an ULTRA system for a gas-fired package boiler which can used at multiple customer locations. Fuel Tech's ULTRA process provides for the safe and cost-effective on-site conversion of urea to ammonia for use as a reagent where Selective Catalytic Reduction (SCR) is used to reduce NOx, eliminating the hazards associated with the transport, storage and handling of anhydrous or aqueous ammonia. Deliveries are expected to be completed in the first quarter of 2024. In addition, change orders were received related to our ULTRA system for previously announced projects on the West Coast and for two current SNCR projects, with work in each case expected to be completed in the third quarter of 2023.

16:11 EDT PCB Bancorp announces stock buyback for up to 720K shares of common stock - PCB Bancorp announced that on August 2, 2023, its Board of Directors approved a stock repurchase program authorizing the repurchase of up to 720,000 shares of the Company's outstanding common stock, which is approximately 5% of the outstanding shares. The stock repurchase program expires on August 2, 2024.

16:07 EDT Amazon up 5% after Q2 report, Q3 guidance - Shares of Amazon are up $6.79, or 5%, to $135.70 in after-hours trading.

16:05 EDT Amazon reports Q2 AWS net sales $22.14B vs. $19.74B last year - Amazon reports Q2 AWS operating income of $5.37B vs. $5.72B last year.

16:05 EDT Amgen sees FY23 CapEx about $925M

16:02 EDT Booking Holdings CEO says continued to see robust leisure travel demand in Q2 - "In the second quarter, we continued to see robust leisure travel demand, which helped drive stronger than expected room nights and gross bookings results in the quarter. We have seen these strong trends continue into July, and we are currently preparing for what we expect to be a record summer travel season in the third quarter. We are particularly excited about our recently announced generative AI-enabled travel assistants at both Priceline and Booking.com, and look forward to learning which elements customers value the most," said Glenn Fogel, CEO of Booking Holdings.

16:00 EDT Hainan Manaslu Acquisition Corp trading resumes

15:32 EDT Sanofi says CDC panel unanimously recommends use of Beyfortus for infants - The U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, or ACIP, voted unanimously 10 to 0 to recommend routine use of Sanofi (SNY) and AstraZeneca's (AZN) Beyfortus for the prevention of respiratory syncytial virus, or RSV, lower respiratory tract disease for newborns and infants below 8 months of age born during or entering their first RSV season, Sanofi announced. "The Committee also voted unanimously 10 to 0 to recommend routine use of Beyfortus for children aged 8 to 19 months who are at increased risk of severe RSV disease and entering their second RSV season. Additionally, the ACIP voted unanimously 11 to 0 to include Beyfortus in the Vaccines for Children program. Beyfortus will be available in the U.S. ahead of the upcoming 2023-2024 RSV season," Sanofi said.

15:16 EDT Camping World closes on asset, real estate purchases of Crain RV in Arkansas - Camping World Holdings announced that it has closed on the asset and real estate purchases of Crain RV in Little Rock, Arkansas and Springdale, Arkansas. Upon the completion of certain facility renovations, the Company intends to open these locations as Forest River RV Little Rock and Alliance RV Northwest Arkansas.

14:50 EDT Lisata Therapeutics malignant glioma treatment granted FDA orphan status - Lisata Therapeutics' treatment of malignant glioma was granted orphan designation by the FDA. Reference Link

14:39 EDT SAM.gov post indicates DOE award to Ameresco - The base and all options value, or total contract value, is listed as $5,000,000,000 on the SAM.gov post. Reference Link

13:33 EDT Crown Electrokinetics urges holders to vote for proposals on Nasdaq compliance - Crown Electrokinetics Corp. said it, "reminds its shareholders to vote for the proposed amendments contained in its Form DEF 14A, filed with the SEC on July 21, 2023, in preparation for its August 11, 2023 shareholder meeting. Each of the management proposals is an important element of Crown's plan to maintain its listing on the Nasdaq Capital Market and fund its future operations and development. If your shares of the Company's common stock are held in the name of a broker, bank or other nominee, in order to vote, you will need the control number which appears on your proxy card."

13:27 EDT Blue Lion believes HomeStreet should 'immediately' sell FNMA DUS license - Blue Lion Capital, an investment firm that says it beneficially owns approximately 2.0% of the stock of HomeStreet, announced that it has issued a letter to shareholders regarding the Bloomberg News article dated August 1 that HomeStreet Bank is exploring options including a sale, stating in part: "Blue Lion believes that HomeStreet should immediately proceed with a sale of its FNMA DUS license and use the proceeds from the sale to re-position its balance sheet and remove the concerns regarding the viability of the bank... This is not the first time that Blue Lion has made comments regarding HomeStreet and its DUS license. On June 13, 2019, after Dwight Capital made an offer to purchase the DUS license and associated mortgage servicing rights form HomeStreet, Blue Lion issued a press release encouraging the Board of Directors to fully engage with Dwight Capital and other interested parties to determine the value of the license."

12:32 EDT National CineMedia effects 1-for-10 reverse stock split - National CineMedia has effectuated a 1-for-10 Reverse Stock Split of its Common Stock. The Company's Common Stock will automatically begin trading on a split-adjusted basis at the opening of the market on August 4, 2023, under the existing trading symbol "NCMI." At the Special Meeting of Stockholders held on August 2, 2023, the Company's stockholders approved a Reverse Stock Split at a ratio range between 1-for-10 and 1-for-100. Following the Special Meeting of Stockholders, on August 2, 2023, the Company's Board of Directors voted to approve the Reverse Stock Split and established a 1-for-10 ratio. The Reverse Stock Split will impact all shares of Common Stock and reduce the number of public shares from 174,191,498 to approximately 17,419,150. The Reverse Stock Split will enable the Company to fulfill its obligations under the Restructuring Support Agreement between the Company, NCM LLC and certain of NCM LLC's secured lenders, and moves NCM LLC one step closer to achieving its Chapter 11 Plan of Reorganization. The Reverse Stock Split is also expected to allow the Company to regain compliance with the $1.00 minimum average closing price requirement of Nasdaq.

12:18 EDT BT Brands files lawsuit against Noble Roman, directors - The company said, "BT Brands in an important step in its effort to achieve a fair vote for Noble Roman shareholders, together with CEO Gary Copperud, on August 2, 2023, filed a lawsuit in Federal Court for the Southern District of Indiana naming both the Company, Noble Roman's, and its Directors as Defendants. The suit alleges that the Company and its Directors violated federal law in omitting material information from its Definitive Proxy Statement, that the Company and its Directors have violated their fiduciary duties in attempting to prevent BT Brands' nomination of Mr. Copperud, frustrating the expressed will of an overwhelming number of shares. The lawsuit notes that Mr. Copperud was recognized as an approved candidate for election as a director at the July 6, 2023, Noble Roman annual meeting of stockholders, scheduled for August 10, 2023. A recent tabulation of votes shows shareholders favor Gary Copperud, BT Brands, Inc.'s nominee, leading Scott Mobley, NROM's nominee, by several million votes representing nearly a 3.5:1 margin of potential victory. Also, today, BT Brands and Mr. Copperud together filed a motion requesting the Court to order the Company and its Directors to hold an annual meeting at which Mr. Copperud's nomination will be duly considered, the votes in his favor counted, and the results of the shareholders' directive respected. Owning a combined stake of more than 8% of NROM shares, BT Brands nominated Mr. Copperud to serve as a director of NROM to add a fresh perspective to its board, including reviews of policies concerning executive compensation and corporate borrowing. In a move made after it became clear that Mr. Copperud would defeat Mr. Scott Mobley, just nine days prior to the original shareholder annual meeting date, NROM declared that, despite initially enabling and recognizing Mr. Copperud's nomination, the nomination was deemed to be not in compliance with Noble Roman's Bylaws and therefore, the nomination would not be considered as valid. because BT Brands' and Mr. Copperud's shares were held in brokerage accounts in "street name" rather than in certificate form under a separate listing on the Transfer Agent's shareholder list. Preliminary voting results show that steps to disqualify Mr. Copperud frustrating the shareholders' overwhelming desire to inject fresh ideas onto the board have not damped the shareholders' desire to cthank hoose Mr Copperud to replace Mr. Mobley. As stated publicly, BT Brands expects to continue investigating, including seeking documents required to be produced under Indiana law, NROM's actions and exploring all available remedies under Indiana and Federal law."

12:00 EDT Mistras falls -19.8% - Mistras is down -19.8%, or -$1.53 to $6.21.

12:00 EDT Rush Street Interactive rises 23.2% - Rush Street Interactive is up 23.2%, or 86c to $4.57.

12:00 EDT Electriq Power rises 46.8% - Electriq Power is up 46.8%, or $1.66 to $5.21.

10:44 EDT HRYU Stock trading resumes

10:39 EDT HRYU Stock trading halted, volatility trading pause

10:18 EDT Nuvei, 888 partner to enhance payment experience in the U.S. - Nuvei Corporation has been selected by 888, a global iGaming operator, to boost its card acquiring and local payment method capabilities to accelerate its growth in the large and expanding U.S. iGaming landscape. 888 is leveraging Nuvei's superior technology platform, extensive acquiring reach, instant bank-to-bank payments, and deep knowledge of regulated iGaming markets to maximize payments acceptance and optimize its risk management.

10:05 EDT MYNA Stock trading resumes

10:00 EDT Titan International falls -20.9% - Titan International is down -20.9%, or -$2.65 to $10.05.

10:00 EDT Community Health rises 18.0% - Community Health is up 18.0%, or 74c to $4.88.

10:00 EDT Electriq Power rises 70.1% - Electriq Power is up 70.1%, or $2.49 to $6.04.

09:55 EDT MYNA Stock trading halted, volatility trading pause

09:51 EDT Expedia sees buying back stock opportunistically throughout rest of 2023

09:48 EDT Expedia sees double digit top line growth, margin expansion for FY23

09:47 EDT Wesco falls -18.9% - Wesco is down -18.9%, or -$33.90 to $145.56.

09:47 EDT Herbalife rises 14.4% - Herbalife is up 14.4%, or $2.31 to $18.35.

09:47 EDT Traeger rises 50.0% - Traeger is up 50.0%, or $2.06 to $6.18.

09:40 EDT Forward Air trading resumes

09:38 EDT Sotera Health trading resumes

09:34 EDT Expedia: Travel remains 'top priority' for consumers

09:33 EDT Sotera Health trading halted, volatility trading pause

09:30 EDT Forward Air trading halted, volatility trading pause

09:29 EDT Innovative Eyewear provides interim company update - Innovative Eyewear shared an interim company update regarding the Company's progress in 2023. In June 2023, the Company conducted a successful secondary offering to raise the capital needed to launch smart eyewear collections under its new Nautica, Eddie Bauer and Reebok partnerships, and its forthcoming Bluetooth safety eyewear. Both the Nautica Powered by Lucyd line and the Company's unique Lucyd Safety smart eyewear line are expected to be launched in Q4 2023. The Eddie Bauer and Reebok Powered by Lucyd lines are expected to launch in early Q1 2024. We believe the recent fundraise capitalized the Company sufficiently to manufacture and market all four of these exciting new product lines, as well as make further enhancements to the Lucyd app, which powers seamless connection to ChatGPT on all of our eyewear. These lines represent a significant diversification of the Company's offering that we believe will enable it to reach new segments of the optical and sunglass markets, and will empower the Company with the largest number of styles of any smart eyewear provider. The Company introduced an end-to-end upgrade to its core Lucyd Lyte product offering in February 2023, improving the sound and call quality by adding additional speakers and microphones, increasing the battery life by 50%, and introducing 15 new styles capturing the latest trends in traditional eyewear. The Company has also engineered significant product improvements which are expected to first debut with an upcoming Lyte XL collection in early Q4, and be introduced on all future models including the Nautica line. These product improvements include the development of a proprietary flexible hinge enabling the glasses to fit a wider range of users comfortably, a thinner and more ergonomic temple form factor for enhanced comfort, and further improvements to sound and call quality. The Lyte XL collection is currently expected to launch with six new styles in early Q4. The Company is continuing to develop new innovations to improve its smart glasses and help establish its products as the global standard in smart eyewear. The Company recently launched a new modular retail display system which has so far been deployed in about 20 partner locations, providing an immersive Lucyd brand experience with a 10" video screen, and an optional audio testing station. The display system includes four modular components that can expand to fill any amount of counter space available, and the display can be easily updated with new videos and insert imagery on a seasonal basis. Seven of these display systems are being launched in US duty free stores through the Company's partnership with Privato Duty Free. The Company recently entered into an engagement with a leading key account consultancy with significant experience in retail placement of eyewear. Additionally, the Company recently signed an agreement with a bespoke influencer marketing agency, to promote the Company's products. Finally, the Company continues to grow its retail store footprint and added approximately 25 new optical partner locations in Q2, in addition to the seven duty free locations previously mentioned. In April 2023, we introduced the world's first smart eyewear powered by ChatGPT through our Lucyd App. In August 2023, the Company expects to launch a significant update to the Lucyd App, its patent-pending, voice-controlled onramp to ChatGPT for smart eyewear. This includes the development of an improved user experience, new tools and prompts to help the user get the most out of ChatGPT, a streamlined onboarding experience, and a premium subscription with unlimited access to ChatGPT and additional premium features.

09:27 EDT Merit Medical's WAVE study completes enrollment - Merit Medical Systems announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy pivotal study. Merit's WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis to percutaneous transluminal angioplasty for treatment of stenosis/occlusion in the venous outflow circuit in patients undergoing hemodialysis. Creation and maintenance of an arteriovenous fistula or graft to achieve long-term vascular access is required for patients undergoing hemodialysis. However, progressive stenosis (narrowing) and/or occlusion of blood vessels where the AVF and AVG are located can prevent delivery of hemodialysis, which can have life-threatening consequences. WRAPSODY was developed to help physicians treat patients with stenosis/occlusion in the vessels used for hemodialysis. The WAVE study enrolled 244 patients with AVFs and 113 patients with AVGs across sites in Brazil, Canada, the United Kingdom, and the United States. Merit intends to collect safety and efficacy outcomes throughout the study follow-up period. Merit anticipates filing primary outcomes with the U.S. Food and Drug Administration for Premarket Approval after six months post-enrollment completion. Merit intends to follow patients enrolled in the WAVE study for 24 months following completion of enrollment.

09:24 EDT WPP, Spotify enter strategic partnership - WPP (WPP) and Spotify (SPOT) announced a new global strategic partnership that will enable WPP to offer its clients early access to Spotify's ad products, first-party intelligence and creative ways to reach engaged audiences at scale. As part of the partnership, Spotify will become the first digital audio platform to be integrated directly into WPP's products and solutions. This includes an exploration in connection with Choreograph's insights platform. In this partnership, WPP will look to use Spotify to develop integrations that provide Spotify's first-party occasions insights to help clients understand aggregated listening patterns in order to inform more creative and effective digital audio advertising strategies. WPP will work with Spotify in an effort to deliver thought leadership and scaled training programs for its employees and clients that focus on digital audio creativity and Spotify's ad products. WPP's teams and clients will also benefit from early access to Spotify's neuro-insights research focused on audience trends and insights.

09:21 EDT AngioDynamics completes enrollment for PRESERVE clinical study - AngioDynamics announced the completion of enrollment and final treatment in its Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population PRESERVE. The PRESERVE study demonstrates AngioDynamics' commitment to innovating care delivery," said Juan Carlos Serna, AngioDynamics Senior Vice President of Clinical and Scientific Affairs. "As we mark the completion of enrollment and final treatment in the study, we take another important step towards demonstrating the NanoKnife System's ability to expand treatment options for patients with intermediate-risk prostate cancer and advance our mission to improve patient quality of life. We appreciate the support provided by our PRESERVE study sites and the partnership with the SUO-CTC team in this important effort." Final patient enrollment in the study was initially announced during AngioDynamics' Fiscal 2023 Fourth Quarter and Full-Year Financial Results conference call on July 12.

09:19 EDT Tejon Ranch to aggressively pursue commercial/industrial development - The company said, "The Company will continue to aggressively pursue commercial/industrial development, multi-family development, leasing, sales, and investment within TRCC and its joint ventures. The Company will also continue to invest in its residential projects, including Mountain Village at Tejon Ranch, Centennial at Tejon Ranch and Grapevine at Tejon Ranch. California is one of the most highly regulated states in which to engage in real estate development and, as such, natural delays, including those resulting from litigation, can be reasonably anticipated. Accordingly, throughout the next few years, the Company expects net income to fluctuate from year-to-year based on commodity prices, production within its farming and mineral resources segments, and the timing of land sales and leasing of land within its industrial developments. Water sales opportunities each year are impacted by the total precipitation and snowpack runoff in Northern California from winter storms, as well as California State Water Project, or SWP, allocations. The current SWP allocation is at 100% of contract amounts, so the Company anticipates that demand for its water over the remainder of the year, will be lower than in previous years when the SWP allocation was significantly less. The Company's farming operations during 2023 will continue to be impacted by higher costs of production such as fuel costs, fertilizer costs, pest control costs, and labor costs. Higher than historically normal almond inventory levels are anticipated to have an adverse effect on selling prices for the remainder of 2023. The current subjective estimate for the 2023 almond crop is 2.6 billion pounds which is consistent with 2022."

09:17 EDT Movella launches OBSKUR broadcasting application - Movella Holdings announced the launch of OBSKUR: the first all-in-one broadcasting application for engaging livestreams built on Unreal Engine 5. OBSKUR makes it easy for anyone to create compelling 3D streams, build a community, and efficiently interact with their audience.

09:16 EDT Alset Capital Acquisition announces update of target's membership program - Alset Capital Acquisition provided updates regarding its planned business combination target, HWH International, HWH. HWH announced updates on its membership program. HWH plans to roll out HWH lifestyle memberships that provide across the board discounted access to the wide range of products and services offered by the group. HWH has four membership tiers - Classic, Premium, Elite, and Black Diamond - which are designed to cater to the diverse preferences and needs of our esteemed members. The membership program, depending on its tier, will encompass differentiated offerings from the four core pillars of HWH: HWH Marketplace, Hapi Cafe, Hapi Travel Destination and Hapi Wealth Builder.

09:14 EDT Illumin integrates with Broadsign to enhance its advertising platform - Digital ad tech company illumin and digital out-of-home, DOOH, ad tech developer Broadsign announced that they have teamed up to integrate the Broadsign supply-side-platform, SSP, with illumin's journey advertising platform. The collaboration makes the platform a one-stop shop for cross-channel marketing by bringing premium global DOOH inventory to illumin for the first time, just as more advertisers are doubling down on a full-funnel approach. "DOOH has grown to become a critical part of journey marketing, so as we continue to look to the future, expanding our platform to include this important facet of programmatic advertising is crucial. The ability to plan, optimize, and measure in one place is unique to illumin, and when it comes to adding DOOH to our platform, we want to partner with the best, making Broadsign an obvious choice," said Andrey Feldman, Vice President of Products at illumin. "Our work together will enhance the illumin platform by providing marketers access to a massive pool of premium DOOH inventory in one easy-to-use, connected canvas. It's a testament to our continued commitment to help redefine the industry's cross-channel journey."

09:14 EDT JetBlue and Air Serbia announce new codeshare agreement - JetBlue and Air Serbia announced a new partnership making Air Serbia-operated flights available on JetBlue.com with a new codeshare agreement. Beginning July 26, JetBlue placed its "B6" airline code on Air Serbia-operated nonstop flights from New York's John F. Kennedy International Airport JFK and Chicago's O'Hare International Airport to Belgrade's Nikola Tesla Airport BEG. Additionally, JetBlue plans on placing its "B6" code on other flights between Belgrade and points in Europe in the near future. Air Serbia plans to add their "JU" airline code to 25 destinations throughout the JetBlue network. "We continuously look to expand our partnerships to offer more options to our customers. Air Serbia has been a successful interline partner since 2016 and we see great potential with this new codeshare," said Robin Hayes, chief executive officer, JetBlue. "We welcome customers from Air Serbia aboard our flights, so they can experience our low fares and great service." "We are very pleased with the future collaboration with JetBlue and believe that this significantly enhances the travel possibilities between the United States and destinations within the Air Serbia network, especially those in the broader Balkan region," said Jiri Marek, chief executive officer of Air Serbia.

09:12 EDT American States Water announces 8.2% boost to quarterly dividend - On August 1, the Board of Directors of American States Water C approved an increase in the company's third quarter cash dividend from $0.3975 per share to $0.4300 per share on the common shares of the company. The annualized dividend rate after this increase is $1.72 per share, which represents an 8.2% increase from the current annualized dividend rate of $1.59 per share. This action marks the 349th consecutive dividend payment by the company. American States Water Company has paid dividends every year since 1931, increasing the dividends received by shareholders each calendar year for 69 consecutive years, which places it in an exclusive group of companies on the New York Stock Exchange that have achieved that result. The company has achieved an 8.1% compound annual growth rate in its calendar year dividend payments from 2013 - 2023. The company's current policy is to achieve a compound annual growth rate in the dividend of more than 7% over the long-term. "This significant dividend increase reflects American States Water's strength and our Board's confidence in the company's ability to achieve long-term, sustainable earnings growth," said Robert J. Sprowls, President and CEO of American States Water Company. "A growing dividend allows the company to attract capital for investments in its infrastructure that enable us to provide safe and reliable services to our customers." Dividends on the common shares will be payable on September 1, 2023 to shareholders of record at the close of business on August 15, 2023.

09:09 EDT LegalZoom launches 'LZ Books' for small business owners - LegalZoom announced LZ Books, an online accounting solution developed specifically to empower solopreneurs to effectively manage their books, secure new work, and be prepared for tax time, all with a budget-friendly solution. LZ Books provides a simple, automated accounting offering as well as the ability to send unlimited, custom-branded proposals and invoices, receive payments 24/7 from clients, link bank accounts for automated income and expense categorization, and access month-over-month cash flow trends. Plus, customers utilizing LZ Books will have an easier time come tax season, and those who have an LZ Tax plan can seamlessly transfer their data to an LZ Tax expert to save even more time and maximize their tax outcome.

09:09 EDT TRxADE HEALTH appoints Fisher as COO, Bortone as CI&FTO - TRxADE HEALTH which recently merged with Superlatus announced the appointments of Forbes Fisher as Chief Operating Officer, COO, and Dr. Eugenio Bortone as Chief Innovation & Food Technology Officer, CI&FTO. Most recently, Fisher served as COO of MOKU Foods. Bortone has held several positions in PepsiCo (PEP) that included Sr. Global Technical Extrusion Leader, and Senior Scientist for the Global Nutrition Group.

09:06 EDT WaterStone Bank will be upgrading to nCino Cloud Banking Platform - nCino announced that WaterStone Bank will be upgrading its technology stack and migrating its commercial, consumer, and residential lending activities to the nCino Cloud Banking Platform. "WaterStone selected the nCino Cloud Banking Platform as a strategic move to help us consolidate and streamline our lending processes across all lines of business," said Ryan Gordon, EVP and Chief Credit Officer at WaterStone Bank. "By utilizing a single platform that delivers a true end-to-end lending experience, we will be empowered to deliver more seamless experiences to our customers while gaining efficiencies and added transparency across our operations and portfolio. I'm excited about this partnership and the path forward."

09:05 EDT Williams in pact with Chattanooga Gas to provide low-emissions NextGen gas - Williams (WMB) announced the execution of an agreement with Chattanooga Gas, a subsidiary of Southern Company Gas, to provide certified, low-emissions NextGen Gas over a 3-year period. Through its Sequent Energy Management business, Williams has built a marketing platform to sell trusted low-carbon and net-zero NextGen Gas to utilities, LNG export facilities and other clean energy users with the goal of helping customers reduce emissions and meet their climate commitments. The delivery of NextGen Gas will allow Chattanooga Gas to achieve a minimum annual emissions reduction savings of approximately 646 tons of methane, or 16,152 tons of carbon dioxide, which is roughly equivalent to removing the emissions from more than 3,500 gasoline-powered automobiles from the road for one year. "As we look to a low-carbon energy future, Williams is committed to leading our industry with credible solutions to benefit our customers," said Chad Zamarin, Executive Vice President of Corporate Strategic Development for Williams. "We are proud to work with Chattanooga Gas to provide clean energy solutions through our NextGen Gas program that proves the quality of low-carbon intensity natural gas. Through our industry-leading Sequent marketing platform and large-scale infrastructure network, we are committed to connecting the best U.S. production basins with credible low-carbon solutions that help our customers meet their sustainability goals."

09:04 EDT AMD announces AMD Radeon PRO W7000 Series - AMD announced two new additions to the AMD Radeon PRO W7000 Series product line: the AMD Radeon PRO W7600 and AMD Radeon PRO W7500 workstation graphics cards. The new graphics cards are designed to tackle mainstream workloads across a range of professional industries, including Media & Entertainment, Design & Manufacturing, and Architecture, Engineering & Construction.

09:03 EDT Riot Platforms produces 410 bitcoin in July - Reports average bitcoin produced per day 13.2. Reports bitcoin held 7,275. "Riot had another strong month in July amidst some of the most challenging operating months of the year, as temperatures in Texas have soared," said Jason Les, CEO of Riot. "Riot's self-mining operations mined 410 Bitcoin in the month of July, while our power strategy generated $6.4 million in power credits and $1.8 million in demand response credits. Our team was able to navigate rapidly changing power market and Bitcoin mining conditions in order to maximize value on a real time basis through our power strategy."

09:01 EDT LiqTech and Nanjing Wondux sign MOU - LiqTech International and Nanjing Wondux Environmental Protection Technology have entered into a memorandum of understanding, or MoU, to explore the application of LiqTech's advanced filtration system to industrial water treatment in China. Nanjing Wondux was established in 2007 and is a listed company on the Science and Technology Innovation Board of the Shanghai Stock Exchange under the stock code: 688178. Nanjing Wondux is an expert in intelligent environmental governance and resource utilization with a focus on garbage pollution control, zero discharge of industrial wastewater, recycling of waste salt, extraction of new energy materials, etc., and provides customers with advanced environmental technology equipment, system integration and overall solutions to environmental problems. Wondux has extended customer groups across China and a good reputation in environmental waste and water treatment area.

08:59 EDT American Resources enters binding LOI to sell certain assets of American Carbon - American Resources has entered into a binding letter of intent to sell certain assets of American Carbon Corporation that are associated to the Company's Deane Mining Complex for a total enterprise value consideration of approximately $20.6 million. This consideration is payable to the Company in the form of an upfront cash payment, ongoing quarterly cash payments for up to $10.5 million, and the assumption of certain environmental reclamation bonds associated with related permits. The structure of the sale transaction is $1.0 million upfront, which includes an already received $200,000 deposit, $500,000 quarterly cash payments thereafter for a total cash consideration of $11.5 million, and the assumption and replacement of approximately $9.1 million in environmental reclamation bonds.

08:57 EDT Terra Property Trust delivers new merger proposal to Western Asset Mortgage - Terra Property Trust released the below letter sent to the board of directors of Western Asset Mortgage: "I write to you on behalf of Terra Property Trust, Inc. ("TPT" or "we") to reaffirm our commitment to consummating a merger with Western Asset Mortgage Capital Corporation ("WMC" or "you"). We firmly believe that a merger between TPT and WMC is the best path to maximizing value for WMC stockholders because it provides for, among other things, enhanced scale, a more diversified portfolio, and a stronger balance sheet. With that context in mind, we are pleased to submit an enhanced cash-and-stock proposal (the "TPT Enhanced Proposal") on terms that are clearly superior to the AG Mortgage Investment Trust, Inc. ("MITT") bid. We trust that you will thoroughly and objectively evaluate the TPT Enhanced Proposal in accordance with both the terms of our Merger Agreement and your fiduciary duties as directors. Relative to MITT's unsolicited bid, you will find that the TPT Enhanced Proposal delivers significantly greater overall value to WMC stockholders by providing more cash, perpetually reduced management fees, and greater certainty of closing. A TPT-WMC merger also positions stockholders to benefit from what you acknowledged is "the partnership of a well-capitalized institutional partner in TPT, which brings a proven track record and has developed broad and deep expertise investing across cycles, property types, and markets." Through the contemplated merger, TPT plans to set a new standard in the mortgage REIT industry by better aligning the external manager's incentives with stockholders' interests. Specifically, we propose a structure that reduces fixed management fees and incentivizes performance. Our proposal seeks to correct the misalignment of interests between external managers and stockholders that MITT has exemplified by charging stockholders high fees that are paid to its external manager, AG REIT Management, LLC, a subsidiary of Angelo, Gordon & Co., L.P. ("Angelo Gordon"). WMC's stockholders deserve better. Notable terms of the TPT Enhanced Proposal include the following: Total Value: TPT is offering WMC stockholders $15.96 per share (including $1.43 per share / $8.75 million in cash), significantly exceeding the total $10.60 per share (including $1.06 per share / $7.0 million in cash)2 that MITT is offering.3 Furthermore, the cash component of MITT's unsolicited bid is uncertain and exposes stockholders to downside risk, as MITT has noted that its cash offer is subject to reduction and is capped at 9.9% of the merger consideration to avoid having to repurchase the outstanding WMC convertible notes. Management Fee: TPT proposes to reduce the asset management fee paid to the external manager to 1.25% of stockholders' equity, compared to the 1.50% proposed by MITT. MITT's proposed one-time $2.4 million management fee waiver is diminished by the following: (a) the waiver does not even offset the $3.0 million termination fee that WMC would be required to pay to TPT and (b) less than one-third of the waiver goes to WMC stockholders.5 In contrast, the TPT Enhanced Proposal provides perpetual savings, initially of $1.0 million per annum (or ~$10.0 million over 10 years), which will become increasingly meaningful as the combined entity's equity grows. Our proposed 1.25% management fee would be the third lowest among 24 externally managed mortgage REIT peers.6 We are putting excess cash where it belongs: in stockholders' hands. Public Market Test: MITT's suggestion that its stock is more attractive than TPT's is deeply flawed for the following reasons: It would be challenging for TPT-WMC to perform as poorly in the public sphere as MITT has. Since the end of 2019, MITT has (a) suffered more than 80% declines in book value and share price, (b) faced widespread margin calls, (c) completed dilutive equity raises, and (d) traded at substantial discounts to book value and peers. Despite MITT's association with a large asset manager, the reality is that TPT's book value exceeds MITT's by more than 40%,7 a critical difference to WMC stockholders given the importance of scale in the mortgage REIT industry. The misalignment between MITT's external manager and its stockholders is evident by Angelo Gordon, a firm with $73 billion of AUM, owning less than $2 million of MITT shares. TPT, by contrast, owns more than triple that amount of MITT's shares. We have been an SEC reporting company since 2019 and have two bond offerings that trade publicly on the NYSE. The reverse merger structure considered in the TPT-WMC merger agreement has a precedent of success, including the mergers of Ready Capital / ZAIS Financial and Benefit Street / Capstead, both of which trade, on a price-to-book value basis, at the higher end of mortgage REIT comps and at substantial premiums to where MITT trades. Post-Merger Trading: The TPT-WMC merger proposal protects WMC stockholders by subjecting TPT (but not WMC) stockholders to staggered conversion rights in the combined company (in equal 6-, 12-, and 18-month increments after the merger), which will mitigate potential selling pressure. The MITT Competing Proposal contains no such protections, making the potential MITT-WMC entity vulnerable to substantial selling pressure post-merger. Certainty of Closing & Timing: We are prepared to file the S-4 proxy statement for the TPT-WMC in the upcoming days and anticipate closing the merger by Q4 of this year. In contrast, a merger with MITT is much less likely to close this year given MITT trails TPT in diligence and filing the S-4. The TPT-WMC merger is also more likely to win stockholder approval, as 80% of TPT shares have agreed to vote in favor of the TPT-WMC merger pursuant to an executed voting agreement.11 Conversely, MITT stockholder approval of a potential MITT-WMC merger is questionable due to MITT having no such voting commitment. The table in Appendix A simplifies the comparison between the TPT Enhanced Proposal and MITT's bid, showing how the TPT Enhanced Proposal is superior for WMC stockholders in every regard. While we respect that you need to uphold your fiduciary duties by considering the MITT bid, we also believe the facts now speak for themselves when it comes to the best path forward for WMC's stockholders. We are prepared to take all necessary steps to protect our interests and position stockholders for the best future. We look forward to a speedy and orderly completion of our transaction."

08:54 EDT American Eagle announces COO Michael Rempell leaving - American Eagle Outfitters announced that Michael Rempell, Chief Operations Officer, has made the decision to leave the company in early fiscal 2024. After over 23 years with AEO, Michael has decided to pursue personal interests and spend more time with his family. The company has commenced a search for a successor and Michael will stay on to ensure a smooth and successful transition. Jay Schottenstein, AEO's Executive Chairman of the Board and Chief Executive Officer commented, "For over two decades, Michael has been a valuable member of our executive team and I am grateful for his numerous contributions... "

08:52 EDT Nitches, Inc. announces collaboration with NBA Atlanta Hawks luxury suites - Nitches announced its resounding success at the recent Association of Luxury Suite Directors Conference and Tradeshow. The event has paved the way for exciting opportunities, including a prestigious collaboration with the Atlanta Hawks luxury suites, where the company will design and manufacture executive staff clothing. The team at Nitches is deeply honored to work with the Hawks and extend their expertise in providing premium clothing experiences. Nitches has been securing potential projects with various sports teams, stadiums, and organizations, set to take place in Q3 and Q4. Regarding Tover, Nitches is thrilled about the brand's potential to enter premium sections of various sports teams' lounges. While specific teams cannot be disclosed at this time, due to the nature of the negotiations, Nitches is excited to provide sports enthusiasts with the opportunity to enjoy Tover Whiskey during their favorite team's victories. In fact, the Company has been in talks with several luxury suite directors for various MLB, NBA and NCAA teams to provide a Tover Branded Bar and custom Spirits for winning celebrations.

08:51 EDT Environmental Solutions Group, Genesis Unicorn close business combination - Environmental Solutions Group and Genesis Unicorn Capital Corp. (GENQ), a special purpose acquisition company, announced the successful closing of their previously announced business combination. The Business Combination was approved at a special meeting of Genesis stockholders on July 26, 2023, and closed on August 2, 2023. The combined company is named ESGL Holdings Limited and will be led by ESA's existing management team. The combined company's common stock and public warrants are expected to begin trading on August 4, 2023, on the Nasdaq under the ticker symbols "ESGL" and "ESGLW," respectively. "The closing of the transaction and our listing on Nasdaq is an important milestone and an incredibly proud moment for the entire ESGL team," said Quek Leng Chuang, Founder, CEO, and Chairman of the Board of ESGL. "ESGL is uniquely positioned to harness the momentum of Singapore's sustainability drive and carbon reduction objectives. With our commitment to innovative technologies and renewable energy, we effectively convert industrial waste into circular products, aligning with our core mission. This strategic transaction bolsters our access to capital, empowering us to seize multiple avenues for growth. As we advance our mission of circularity and sustainability, we enable our partners to reduce their environmental impact, contributing to creating a more resilient planet."

08:47 EDT Ballard Power signs LOI with Ford Trucks - Ballard Power Systems announced the signing of a letter of intent, or LOI, with Ford Trucks to supply a fuel cell system as part of the development of a hydrogen fuel cell powered vehicle prototype. The partnership includes an initial purchase order for 2 FCmove-XD 120 kW fuel cell engines that are planned to be delivered by Ballard to Ford Trucks in 2023. Ford Trucks, the global brand of Ford Otosan, plans to develop a Fuel Cell Electric Vehicle (FCEV) F-MAX as part of the project. The 120 kW FCmove-XDTM fuel cell engines are planned to be integrated into Ford Trucks' F-MAX 44-ton long-haul tractor truck.

08:46 EDT Jacobs selected by Port of Seattle for renovation of the Seattle-Tacoma airport - Jacobs was selected by the Port of Seattle to lead and manage the 10-year renovation of the S Concourse at Seattle-Tacoma International Airport, or SEA. Modernizing the 50-year-old concourse includes improving operating systems, environmental efficiencies, and earthquake resiliency, prioritizing seismic updates. Jacobs will provide full project management services, including project controls, estimating and scheduling support, development of enabling facilities supporting phase construction (airside, terminal, utilities), and a complete gate utilization strategy. In addition, Jacobs will provide advisory services for passenger flow analysis, airport and airline tenant engagement, and evaluation of sustainable building opportunities such as rainwater harvesting, eliminating the use of natural gas and the installation of sustainable alternative power sources, including solar energy.

08:45 EDT Navitas Semiconductor provides update on CRPS185 3,200 W server design - Navitas Semiconductor announced that its CRPS185 3,200 W "Titanium Plus" server reference design not only surpasses the stringent 80Plus Titanium efficiency requirements, but also effectively satisfies the increasing power demands of AI data center power. The rapid development and deployment of artificial intelligenceincluding OpenAI's ChatGPT, Microsoft's Bing with AI, and Google's Bard, has penetrated all aspects of people's lives. New power-hungry AI processors like NVIDIA's DGX GH200 'Grace Hopper' demand up to 1,600 W each, are driving power-per-rack specifications from 30-40 kW up to 100 kW per cabinet. Meanwhile, with the global focus on energy conservation and emission reduction, as well as the latest European regulations, server power supplies must exceed the 80Plus 'Titanium' efficiency specification.

08:43 EDT GTECH selects WooRank to power revenue growth - Bridgeline Digital announced that GTECH, a global full-service digital marketing company, has chosen, WooRank, its innovative SEO product to power their revenue growth. The technology powerhouse will leverage the WooRank SEO tool to accelerate its lead generation success. The company has delivered cross-media solutions to over 300 businesses worldwide, including esteemed Fortune 500 clients such as Standard Chartered, Red Bull, Ford, IBM, SAP, Johnson & Johnson, and Cisco

08:43 EDT Workhorse Group mails letter to stockholders from CEO Dauch - Workhorse Group mailed a letter to Workhorse stockholders from its CEO Rick Dauch providing context on why Workhorse stockholders should vote FOR the proposal to increase the number of authorized shares of Workhorse common stock in connection with the upcoming Special Meeting. "I am reaching out so you can hear directly from me about where Workhorse is today and why we need your help to build a bridge to continued growth and long-term stockholder value creation. We are asking our stockholders to approve an increase in our authorized common stock and I am asking for you to support the future of Workhorse by voting in favor TODAY. To facilitate our growth, we have revitalized our facilities, bringing manufacturing and jobs back to the Midwest... We have developed and are advancing a clear product roadmap, targeting the CL4-6 work truck and step-van segment... At the same time, we are building out our commercial footprint. We have announced partnerships with several regional EV dealers and are continuing to expand our dealership network further in the coming years. In addition to our commercial EVs, we have continued to invest in our Aerospace business and pursue key contracts... Finally, we have strengthened the Company's financial position.... That said, as we look ahead, we need to ensure we have the necessary financial resources to "complete the transition" and are evaluating a range of options to fund our next phase of production and profitable growth... This is why we need your help to build a bridge to continued growth and long-term stockholder value. To continue on our journey, we need our stockholders to vote FOR the proposal to increase the number of authorized shares of Workhorse common stock."

08:41 EDT TeraWulf reports July 2023 production, operations update - TeraWulf provided an unaudited monthly production and operations update for July 2023. July 2023 Highlights: Self-mined 330 bitcoin in July with an average production rate of 10.6 bitcoin per day. Power cost averaged $12k per bitcoin produced, or approximately $0.042/kWh in July. Delivered the highest monthly self-mining revenue in WULF history despite July's challenging weather and grid conditions. During July, the Company completed installing its remaining miners to completely utilize available capacity and bring Lake Mariner's operational hash rate to a total of 3.6 EH/s, and the Company's total operational hash rate to the full 5.5 EH/s and 160 MW of capacity across its two sites. As of July 31, 2023, the Company had an operational miner fleet of approximately 50,000 of the latest generation miners, comprised of 34,000 miners at its wholly owned Lake Mariner facility in New York and 16,000 self-miners at the nuclear-powered Nautilus facility in Pennsylvania.

08:40 EDT Assure Holdings acquires assets from Innovation Neuromonitoring for $1.2M - Assure Holdings has acquired certain assets of Innovation Neuromonitoring for approximately $1.2 million in a cash and equity transaction.

08:39 EDT TripAdvisor: Generative AI travel itinerary feature still in public beta - Says early metrics "promising," user satisfaction scores already approaching nearly 70% positive feedback. Comments taken from Q2 earnings conference call.

08:38 EDT Versus Systems enters cooperation agreement with eGrowcery - Versus Systems announced that it has entered into a cooperation agreement with eGrowcery, a leading retail food industry white-label eCommerce platform, to use Versus' AI and interactive products with eGrowcery's clients in the grocery, liquor and convenience store space. Versus and eGrowcery have also signed a software license agreement for a new AI-powered recipe tool, designed to drive supplemental sales and enhance the shopper's experience. "Our goal at Versus is to use interactivity and rewards to make any experience more fun and engaging. We are excited to partner with eGrowcery to use AI to enhance the shopping experience," said Matthew Pierce, CEO of Versus Systems. "By adding our proprietary technology to the industry-leading eGrowcery platform, we hope to benefit both the shoppers and the stores that work with eGrowcery - and we hope end users will find new recipes that their families will love."

08:37 EDT Alarum announces NetNut has secured first AI recruitment market customer - Alarum Technologies announced that its Enterprise Internet Access arm, NetNut, has secured its first Artificial Intelligence recruitment market customer for its recently launched cloud-based digital technologies and analytics. The client utilizes AI and machine learning to modernize and streamline background checks, promoting transparency, fairness and efficiency in the talent's hiring process for a more equitable future of work. "We are proud that one of the leading names in the recruiting industry has chosen to partner with NetNut. We believe that this collaboration reinforces NetNut's position as one of the biggest brands in our sector in addition to highlighting our unwavering commitment to innovation and excellence. As we move forward, this collaboration will unlock new avenues for growth," said Shachar Daniel, Chief Executive Officer of Alarum.

08:35 EDT Biomerica announces CVS has begun rollout of its EZ Detect colorectal test - Biomerica (BMRA) announced that CVS Pharmacy (CVS) has begun in-store sales rollout of the Company's EZ Detect colorectal disease screening test in over 7,000 stores nationwide throughout the CVS Pharmacy retail system. Biomerica has shipped the EZ Detect product to CVS Health distribution centers in the US, and the product is projected to be on store shelves in September. The Company is also working with CVS Health to introduce an additional Biomerica product to be sold in CVS pharmacies. "We're excited to broaden the distribution of EZ Detect in the US," commented Zack Irani, CEO of Biomerica. "CVS Pharmacy is the largest Pharmacy system in the USA. Each day, approximately 5 million customers visit a CVS Pharmacy. Early detection is a key factor to beating colorectal cancer. The inclusion of EZ Detect(TM) on CVS Pharmacy shelves is a significant development in making our easy and innovative in-home tests available to more patients."

08:34 EDT Blink Charging to deliver charging solutions for Nashville-Davidson County - Blink Charging announced it has been selected as an EV charging solutions provider for the Metropolitan Government of Nashville-Davidson County in Tennessee. The exciting new agreement empowers local agencies to acquire Blink's state-of-the-art EV charging equipment for locations across the county, with the chargers being supplied by Blink and owned by Metro.

08:33 EDT InterDigital announces new white paper on extended reality opportunities - As new devices entice the consumer XR market, a new white paper commissioned by InterDigital and written by market research firm ABI Research, details the standards, solutions, and emerging challenges shaping new extended reality opportunities. The report, "Defining the XR Experience: Enabling the Immersivity Ecosystem," introduces the strong foundation of wireless and video innovation that underpin the spectrum of XR experiences, including AR, VR, and MR, and stresses the importance of standards to ensure compatibility and combat technology fragmentation across the various devices, networks, and systems that empower XR experiences. "Today's XR capabilities are forged from innovations in wireless and multimedia that enable us to capture audio, video, haptic, and kinesthetic data into one scene representation and transmit that complex XR traffic across our networks to achieve a seamless blend of our physical and virtual worlds," said Rajesh Pankaj, CTO, InterDigital. "These new "realities" would be impossible without long-term research and contributions to standards from companies like InterDigital, which help improve network capabilities, evolve compression techniques, and ensure the interoperability of devices and services for this growing ecosystem."

08:31 EDT Iris Energy mines 423 bitcoin in July - Corporate: Record data center operations at 111 degrees F intake temperatures; Maintained stable hashrate through extreme temperatures; Demonstrates Iris Energy's industry-leading data centers; Further validates proprietary air-cooled data center design; Appointment of Sunita Parasuraman to Board of Directors; Senior technology executive. Operations: Average operating hashrate of 5,562 PH/s; Monthly operating revenue of US$12.7 million; 423 Bitcoin mined; ~US$0.2 million of estimated power sales at Childress via automated algorithm; Higher electricity costs per Bitcoin primarily attributable to higher prices at Childress during the month and reduced market volatility. The Company retains flexibility to reduce future power costs through adjusting miner output in response to changes in mining economics

08:29 EDT Else Nutrition to introduce Ready-To-Drink Kids Nutritional Shakes - ELSE NUTRITION will introduce its first-ever Ready-To-Drink products in the form of Kids Nutritional Shakes in Vanilla and Chocolate flavors. These will be unveiled at the upcoming Natural Products Expo East in September 2023 at booth 2238. This debut marks the company's significant expansion from its successful powdered product range into the larger, fast-growing RTD market.

08:28 EDT Sterling Check launching virtual I-9 document review service - Sterling Check will be launching a new virtual I-9 document review service in the coming weeks. As part of the existing Sterling I-9 solution, ID.me Trusted Referees will examine documents virtually, securely, and conveniently, enabling employers to complete I-9 requirements remotely for their new hires. ID.me and Sterling's new solution is built upon the recently announced alternative verification procedures from Department of Homeland Security and United States Citizenship and Immigration Services. Instead of relying on in-person review conducted by an employer or 3rd party notary, ID.me's expert Trusted Referees will be available to complete secure virtual document review on behalf of the employer. The ID.me Trusted Referees are screened and trained to Department of Commerce standards for identity proofing set by the National Institute of Standards and Technology. Currently 14 federal agencies and 35 state government agencies rely on ID.me's Trusted Referees to verify users. The virtual document review process will be available to new and existing Sterling I-9 clients who are also E-Verify users in good standing. The entire process can be completed remotely in 5-10 minutes and is compliant with DHS and USCIS requirements. All documents examined by ID.me Trusted Referees are retained along with all other I-9 documents in the Sterling system and available to employers for audit purposes.

08:26 EDT X4 Pharmaceuticals closes $115M loan facility with Hercules Capital - X4 Pharmaceuticals (XFOR) announced the closing of a $115 million loan facility with Hercules Capital (HTGC). The company also announced that it drew down $22.5 million upon the transaction's closing. The term loan facility provides for up to $115 million of term loans in the aggregate, available to be funded in multiple tranches. In addition to its initial drawdown, X4 may, for a period of time following U.S. approval of mavorixafor in individuals with WHIM syndrome, draw an additional tranche of up to $20 million. An additional tranche will be available to X4 in the amount of up to $7.5 million for a period of time following achievement of a certain clinical development-related milestone. The availability of a final tranche of up to $32.5 million in support of X4's growth initiatives is subject to the approval of the lenders. In addition, the availability of each tranche is subject to certain customary conditions to drawing. The facility refinances $32.5 million in outstanding principal indebtedness and extends the initial interest-only period and maturity of existing and future borrowings. X4 is under no obligation to draw funds in the future.

08:25 EDT Canacol Energy says gas sales averaged 197 MMscfpd in July - Canacol Energy provides the following gas sales and drilling operations update. July Gas Sales of 197 MMscfpd: Realized contractual natural gas sales were 197 million standard cubic feet per day for July 2023. Drilling Program: Canacol's near field exploration program includes the successful Lulo discovery, as well as the Pina Norte, Cereza, and Mafaldine prospects. The program is targeting exploration prospects within the proven Cienaga de Oro sandstone reservoirs located close to the Jobo production facility that can be commercialized very quickly, allowing the Corporation to build productive capacity in order to meet the anticipated high demand for gas associated with the upcoming El Nino phenomena. The Corporation spud the Pina Norte 1 exploration well located on its 100% operated VIM21 Exploration and Production contract on June 26, 2023. The well is located approximately 500 meters to the west of the Jobo production facility. The well encountered an over pressured zone in a very shallow reservoir and due to drilling difficulties had to be plugged and abandoned. The twin offset Pina Norte 2 exploration well was spud on July 18, 2023 and is currently drilling ahead. The Corporation anticipates completing the well within the next two weeks. Upon completion of the Pina Norte 2 well, the drilling rig will be mobilized to drill the Mafaldine exploration well, also located on the VIM 21 E&P contract, and situated approximately 1.5 kilometers to the northwest of the Jobo production facility. A second rig is being mobilized to drill the Cereza 1 exploration well also located on its 100% operated VIM 21 E&P contract. The well is located approximately 500 meters to the north of the Jobo production facility. The well is anticipated to spud the second week of August 2023, and is targeting gas charged sands of the Cienaga de Oro reservoir. The well will take approximately 4 weeks to drill and complete. A third rig is being mobilized to drill the Aguas Vivas 4 development well which is also located on its 100% operated VIM 21 E&P contract. The well is anticipated to spud the third week of August 2023 and is targeting the CDO reservoir within the Aguas Vivas field.

08:24 EDT OpGen's subsidiary Curetis, FIND extend R&D collaboration agreement - OpGen reported that its German subsidiary Curetis GmbH has signed an extended and continued research and development, R&D, collaboration agreement with FIND. Following the successful completion of the feasibility phase of the collaboration and having met all milestones on time and within budgets, the parties now plan to collaborate on first phases of product development of an antimicrobial resistance cartridge from blood culture that is tailored to the needs of low- and middle-income countries in terms of panel design and coverage of specific genetic variants of bacterial strains and their AMR markers in such countries, as well as ensuring attractive cost profile and pricing models that allow for access to such rapid testing in LMICs. This extended R&D collaboration now covers the development of an AMR assay and Unyvero A30 cartridge for AMR detection from commonly used blood culture bottles as well as the corresponding software plugin development and full analytical performance evaluation. The expected duration of the development phase is about ten months and the agreed-upon project budget for the extended contract is approximately $0.6 million split into an up-front payment and two milestone payments upon delivery of successful development results.

08:23 EDT Freshworks launches AI-powered Customer Service Suite - Freshworks announced the launch of its AI-powered Customer Service Suite which brings together self-service bots, agent-led conversational messaging, and automated ticketing management in an all-in-one solution. Uniting Freshchat, Freshdesk, and the company's generative artificial intelligence technology, Freddy AI, the Freshworks Customer Service Suite enables a modern customer support experience accessible to any company, with pricing that scales from small business to global enterprise.

08:23 EDT FOREWARN partners with New Orleans Metropolitan Association of REALTORS - FOREWARN announced that New Orleans Metropolitan Association of REALTORS has contracted to make FOREWARN services available for the 6,600+ members they serve throughout New Orleans and the surrounding area to promote proactive real estate agent safety.

08:21 EDT ProPhase Labs partners with Certis Oncology for Linebacker-1 - ProPhase Labs provided an update regarding its progress and development strategy for Linebacker-1, a small molecule, multi-kinase inhibitor that is being developed by the Company's wholly owned subsidiary, ProPhase BioPharma as apotential safer, more efficacious oncology therapy wholly unlike standard chemotherapeutic agents. "ProPhase Labs continues to act as a disruptor in the therapeutic development space by employing only the most advanced, cutting-edge technology in the pursuit of clinical benefit and program success," commented developmental lead Dr. Matt Halpert Ph.D. "Long gone are the days of blind experimentation with the hopes of achieving promising results.. We have entered an era in which if you are not at the forefront of high throughput analysis and technology for therapeutical development, you are not in therapeutical development." With that mindset, ProPhase Labs has joined forces with Certis Oncology to use one-of-a-kind, robust, machine learning technology to exponentially improve the chances of successful development in the oncological therapeutic space.

08:21 EDT Karuna Therapeutics names Jason Brown as CFO, Jonathan Rosin as CHRO - Karuna Therapeutics announced the appointment of Jonathan Rosin to Chief Human Resources Office and the promotion of Jason Brown to CFO. Brown succeeds Troy Ignelzi, who will remain at Karuna for a transition period through the end of the third quarter of 2023.

08:19 EDT Agios Pharmaceuticals announces license agreement with Alnylam - Agios Pharmaceuticals (AGIO) has entered into an exclusive worldwide license agreement with Alnylam Pharmaceuticals (ALNY) under which Agios will acquire the rights to develop and commercialize Alnylam's novel preclinical siRNA targeting TMPRSS6, as a potential disease-modifying treatment for patients with polycythemia vera. This agreement combines Agios' deep scientific expertise and capabilities in rare hematologic diseases with Alnylam's industry-leading siRNA platform and strong track record of success. PV is a rare hematologic disease with no disease-modifying treatments that affects approximately 100,000 patients in the U.S. PV is characterized by excessive production of red blood cells, which leads to increased blood volume and viscosity, and can result in thrombosis, cardiovascular events, and death. Under the terms of the agreement, Agios will make an upfront payment of $17.5M to Alnylam for an exclusive global license to the TMPRSS6 siRNA program. In addition, Alnylam is eligible to receive up to $130M in potential development and regulatory milestone payments, in addition to sales milestones and tiered royalties. Agios will assume sole responsibility for all development, regulatory, and commercial activities and costs related to the program. Alnylam will provide manufacturing support for Phase 1, after which Agios will assume full responsibility for manufacturing.

08:19 EDT Kaival Brands Turning appoints Metzler as CFO, Mosser as CEO - Kaival Brands Innovations (KAVL) announced the appointment of Thomas Metzler as the Company's new Chief Financial Officer, CFO, Treasurer and Secretary, effective as of August 1, 2023, replacing Mark Thoenes, who has served as Interim CFO since 2021. The Company has also promoted its current President & Chief Operating Officer, Eric Mosser, to the position of Chief Executive Officer, CEO. Metzler brings over 20 years of finance and operational experience in the vaping and consumer products sector, previously serving as Managing Director of a Division of Turning Point Brands (TPB).

08:19 EDT Warner Bros. Discovery: Upfront volume 'up,' pricing 'consistent' with past

08:17 EDT Henry Schein to acquire a majority interest in Shield Healthcare, no terms - Henry Schein announced that it has signed an agreement to acquire a majority ownership position in Shield Healthcare, a supplier of homecare medical products delivered directly to patients in their homes. The addition of Shield Healthcare will advance Henry Schein Medical's continuum-of-care delivery model. Headquartered in Valencia, Calif., Shield Healthcare had 2022 net sales of approximately $180M. Henry Schein expects the transaction to be neutral to 2023 non-GAAP earnings per share and accretive thereafter. Closing is subject to standard closing conditions and is expected to be completed in the third quarter of 2023. Financial terms were not disclosed.

08:16 EDT 180 Life Sciences provides update on regulatory process in UK, U.S. - 180 Life Sciences submitted a request to the United Kingdom's Medicines and Healthcare products Regulatory Agency for a follow up scientific advice meeting where the Company will seek guidance on a plan to obtain Conditional Marketing Authorization for the use of adalimumab in the treatment of early stage Dupuytren's disease. A meeting with the MHRA is anticipated to take place in late Q3 of 2023 with the written responses anticipated to be received prior to year end. The Company's regulatory consultants have indicated that initiation of an additional clinical trial may be required to obtain CMA approval, and such a trial has been designed. The regulatory consultants of the Company believe that it may be possible to obtain a CMA due to the long safety history of anti-tumor necrosis factor therapies, conditional on a successful Phase 3 trial, which CMA may be granted prior to the completion of the Phase 3 trial, once patients have been enrolled, verifying the commitment of the Company to complete the trial. A CMA would allow the Company to market its therapy for Dupuytren's disease in the UK, between the granting of the CMA and completion of a successful Phase 3 trial. The Phase 3 trial might utilize sites from various countries, including the United States. Therefore, the Company has submitted a request to the US Food and Drug Administration for a Type C meeting to seek advice as to requirements for obtaining US marketing approval including the potential design requirements of the planned Phase 3 clinical trial. Guidance from the FDA is expected to shape the Company's clinical development strategy in the US and possibly in other countries. In support of our FDA Type C meeting request, a leading pharmaceutical biosimilar manufacturer will be participating with 180 Life Sciences in the FDA advice discussion. It is anticipated that the advice discussion will take place in late Q3 or early Q4 of 2023. Promising data from a Phase 2b Dupuytren's treatment trial was published in the June 2022 issue of The Lancet Rheumatology. A follow up publication showed that the therapy likely would be cost effective, and was economically beneficial.

08:15 EDT Iron Mountain raises quarterly dividend 5% to 65c per share - Payable on October 5 to shareholders of record on September 15.

08:14 EDT Telos' Xacta platform prioritized by FedRAMP JAB - Telos Corporation announced that its cyber risk management and compliance solution, Xacta, has been prioritized by the U. S. Federal Risk and Authorization Management Program to pursue a Provisional Authority to Operate from the Joint Authorization Board. According to the JAB Prioritization Criteria and FedRAMP Connect Guide, "FedRAMP may prioritize up to 12 cloud service offerings per year," and that "the most important criteria for JAB prioritization is to demonstrate government-wide demand for the CSO."

08:13 EDT Nano Dimension implements SAP as Cloud ERP system - Nano Dimension (NNDM) announced the implementation of SAP (SAP) as its new Cloud Enterprise Resource Planning system, which marks a material milestone in advancing the Company's organizational and operational effectiveness. SAP was selected by Nano Dimension after a thorough evaluation of various options available in the market. The decision to implement SAP, and specifically the "RISE with SAP" product, reflects Nano Dimension's commitment to leveraging cutting-edge technology to optimize its business operations and provide superior service to its customers. This is an important step in any business's prioritization to deliver better financial results and drive shareholder returns.

08:11 EDT Landsea Homes purchases 84 finished lots in Liberty Hill, Texas - Landsea Homes announced the purchase of 84 finished lots in the Lariat master-planned community in Liberty Hill, Texas.

08:10 EDT Warner Bros. Discovery: Max has full capability to deliver live programming

08:08 EDT Warner Bros. Discovery has seen lower than expected churn amid Max launch

08:07 EDT Warner Bros. Discovery: Migration to Max has gone 'exceedingly well'

08:07 EDT Warner Bros. Discovery expects U.S. DTC business to be profitable for FY23 - Expects U.S. DTC business to be profitable for FY23, a year ahead of prior guidance.

08:06 EDT Warner Bros. Discovery sees being 'comfortably' below 4x leverage by end of year - Comments taken from Q2 earnings conference call.

07:59 EDT Sonoma Pharmaceuticals appoints Hye Jin Chung to SAB - Sonoma Pharmaceutical announced the appointment of Dr. Hye Jin Chung MD, MMSc, Assistant Professor of Dermatology at Harvard Medical School in Boston and practicing dermatologist at Beth Israel Deaconess Medical Center, to the company's Scientific Advisory Board. Sonoma's Scientific Advisory Board will be comprised of a small group of physicians with expertise in the areas of dermatology, skin care, wound care, eye, oral and nasal care, and animal health. The purpose of this Board is to allow the Sonoma's leadership team to gain insights that will inform the company's research and development activities, efforts to address areas of unmet need, and potential new areas of interest. Dr. Chung is an expert in her field of dermatology with extensive knowledge of skin conditions and treatments.

07:58 EDT The Buckle reports July SSS down 1.3% - The Buckle announced that comparable store net sales, for stores open at least one year, for the 4-week period ended July 29, 2023 decreased 1.3 percent from comparable store net sales for the 4-week period ended July 30, 2022. Net sales for the 4-week fiscal month ended July 29, 2023 decreased 2.6 percent to $95.1 million from net sales of $97.7 million for the prior year 4-week fiscal month ended July 30, 2022. Comparable store net sales for the 13-week second quarter ended July 29, 2023 decreased 3.3 percent from comparable store net sales for the 13-week period ended July 30, 2022. Net sales for the 13-week fiscal second quarter ended July 29, 2023 decreased 3.2 percent to $292.4 million compared to net sales of $302.0 million for the prior year 13-week fiscal second quarter ended July 30, 2022.

07:55 EDT Zinwell adopts Peraso X120 chipset for Ethernet Bridge radio - Peraso announces that Zinwell has adopted Peraso's X120 chipset for its new 2.5Gigabit Ethernet Bridge radio, the ZWR-V622. Utilizing Peraso's phased array antenna technology, the ZWR-V622 enables fiber-speed connectivity without the need or cost of pulling fiber. A 2.4 and 5GHz Wi-Fi back-up are also included for robust availability in all weather conditions. The ZWR-V622 is an easy to install, low-cost solution for bridging networks between buildings and across geographical obstacles, especially in dense urban environments.

07:54 EDT Snail enters cooperation with Wolpertinger Games - Snail entered into a Software Development, Publishing and Distribution Agreement with Wolpertinger Games, an independent studio founded by Sebastian Bender and Remote-Control Productions in 2009. This cooperation aligns with Snail's strategy of amplifying its publishing portfolio through the incorporation of premier games crafted by independent studios, thereby enhancing the global player experience. Pursuant to the Agreement, both parties will leverage their respective time and resources to promote the development and visibility of Wolpertinger's upcoming games Snail, utilizing its accumulated experiences in game publishing and distribution along with its strong international presence, aims to optimize the publishing process, target markets tailored for Wolpertinger, and expedite market entry and penetration. Wolpertinger Games pledges comprehensive support and authorization rights, empowering Snail to distribute and publish its games whilst maintaining the continuous quality of its game offerings. Snail anticipates this collaboration to catalyze business expansion and growth for both parties.

07:52 EDT Labcorp announces partnership with Tufts Medicine - Labcorp announced an agreement with Tufts Medicine, an integrated academic health system in Massachusetts, for Labcorp to acquire the Tufts Medicine outreach laboratory business and select operating assets as a first step toward a larger strategic partnership. Through this new partnership, patients and providers of Tufts Medicine will have improved access to testing, reduced wait-times for patients, and standardized laboratory testing throughout the Tufts Medicine system. The arrangement will provide patients and clinicians access to Labcorp's scientific expertise and advanced diagnostics in areas such as oncology, neurology and women's health. The outreach acquisition is expected to be finalized in October 2023, and is subject to customary closing conditions and applicable regulatory approvals. Additional terms of the transactions were not disclosed.

07:50 EDT Jacobs awarded $450M U.S. EPA contract - Jacobs was awarded a $450M Superfund and Great Lakes Architecture-Engineering Services indefinite delivery/indefinite quantity multi-award contract by the U.S. Environmental Protection Agency's Great Lakes National Program Office and the Region 5 Superfund and Emergency Management Division to provide environmental, technical and management services and associated infrastructure tasks in the Great Lakes Area. The five-year contract allows Jacobs to assist EPA's efforts to clean up and restore 22 of the 25 remaining Great Lakes Areas of Concern by 2030, an ambitious goal made possible by the Bipartisan Infrastructure Law. The work streamlines and accelerates both Superfund and Great Lakes Legacy Act environmental cleanups providing contaminated sediment evaluations, site management, remedial investigations, feasibility studies, remedial design activities, habitat restoration design and evaluation support, and remediation oversight for the lakes and surrounding infrastructure.

07:48 EDT Revival Gold files NI 43-101 preliminary feasibility study technical report - Revival Gold has filed on SEDAR a technical report prepared in accordance with National Instrument 43-101, NI 43-101, - Standards of Disclosure for Mineral Projects on the Beartrack-Arnett Heap Leach Project. The Technical Report supports disclosure made by the Company in its news release dated July 11th, 2023, titled "Revival Gold Marks Impressive Continued Growth in Mineral Resource and Advances Open Pit Heap Leach Restart Plans with PFS".

07:47 EDT Stack Capital reports book value per share of C$11.17 as of June 30 - The Company's cash and collateral position as at June 30, 2023, was C$28.1 million or C$3.12 per share. "We're extremely pleased with the growth trajectory across our portfolio companies - highlighted by developments at Hopper, Locus Robotics, Prove Identity, and SpaceX," said Jeff Parks, CEO of Stack Capital. "Recent activity in the US IPO market indicates that things are slowly beginning to improve; as such, we remain optimistic about the outlook for 2024, along with the potential for some of our companies to be beneficiaries of a revitalized IPO environment."

07:46 EDT Sabre sees FY25 adjusted EBITDA greater than $900M - Sabre's 2025 financial targets for Adjusted EBITDA of greater than $900M, and Free Cash Flow of greater than $500M are unchanged.

07:44 EDT Osino Resources announces update on its Twin Hills Gold Project - Osino Resources provides an update progress with activities in support of the planned development of Osino's Twin Hills Gold Project, following the successful completion of a Definitive Feasibility Study in June 2023. Heye Daun, Osino's President and CEO commented: "The award of this FEED study marks another key milestone for Osino as it moves the Twin Hills Gold Project closer to production. Having worked closely with Lycopodium on successive technical studies over the last few years, we are delighted to have selected them as the engineering lead towards the implementation of the Twin Hills project. Lycopodium is recognized for their gold processing plant design expertise and their world-class track record of on-time and on-budget project delivery in Africa and globally. At the same time, the Osino team is making great strides in further advancing various studies and activities towards completing bulk power and water supply and towards concluding the permitting process for the project."

07:43 EDT Ayr Wellness adds Warren to board of directors - AYR Wellness announced that it has welcomed Michael Warren to the Company's Board of Directors. He previously served on the Board of Directors of Metrodigi, a privately held digital publisher.

07:42 EDT Verrica announces acceptance of abstract on VP-135 for AAD meeting - Verrica Pharmaceuticals announced the acceptance of an abstract that will feature clinical data from the Company's ongoing Phase 2 study of VP-315 for the treatment of basal cell carcinoma, BCC. The presentation is titled "VP-315, an Investigational Non-surgical Immunotherapy in Subjects with Biopsy Proven Basal Cell Carcinoma", and will highlight the antitumor activity of VP-315 as determined by clinical and histological clearance of treated BCC lesions from the Company's ongoing Phase 2 trial. The data will be presented at the 2023 American Academy of Dermatology, AAD, Innovation Academy, which is being held from August 10-13, 2023, in Tampa, Florida.

07:41 EDT Bolt Biotherapeutics initiates Phase 2 studies of BDC-1001 - Bolt Biotherapeutics announced that the first patients have been dosed in a Phase 2 dose-expansion clinical trial investigating BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugatem, ISAC. The trial will explore BDC-1001 monotherapy treatment in three discreet cohorts for patients with HER2-positive colorectal, endometrial and gastroesophageal cancers. "This is an important milestone for our company that builds on the positive signal of monotherapy activity that we observed in the Phase 1 portion of the study," said Edith A. Perez, M.D., Chief Medical Officer of Bolt Biotherapeutics. "Despite considerable advances in anti-cancer therapy, HER2-positive tumors remain difficult to treat, and new therapeutic options are urgently needed. Our ISAC platform brings a novel mechanism with the potential to address refractory and recurrent disease to the treatment of HER2+ cancers and BDC-1001 has demonstrated promise. We are committed to advancing this study for the benefit of the many patients in need."

07:40 EDT Sono-Tek announces $2.19M order from specialty clean energy customer - Sono-Tek Corporation announced that it has received an additional order from an existing clean energy customer. This order is the second part of an expected multi-system program and is valued at $2.19 million. The new order is for three production scale systems and follows an order for one production scale system that is scheduled to ship in the current fiscal year, ending February 29, 2024. The customer initially purchased an R&D system from Sono-Tek for development before progressing to the production scale systems. The new order is planned for shipment during the first half of fiscal 2025. Steve Harshbarger, President and COO of Sono-Tek, commented, "This new order from an existing clean energy customer is our largest from the sector to date and the largest in Sono-Tek's history. It's also the third order from this customer who is building out the production line for their specialty clean energy product after starting with the purchase of an R&D unit and perfecting their manufacturing process with the assistance of our application engineers. Additional orders from this customer are expected after the successful integration of these production systems built with Sono-Tek's proprietary thin film application."

07:35 EDT BridgeBio sees cash runway into 2H24 - Cash, cash equivalents, marketable securities and short-term restricted cash, totaled $353.2 million as of June 30, 2023, compared to $466.2 million as of December 31, 2022. The net decrease of $113.0 million in cash, cash equivalents, marketable securities and short-term restricted cash is primarily attributable to net cash used in operating activities of $257.7 million, offset by net proceeds received of $144.0 million from the Follow-on public offering during the six months ended June 30, 2023.

07:31 EDT Intra-Cellular sees FY23 CAPLYTA net sales $445M-$465M - Sees FY23 SG&A expense $420M-$450M, R&D expense $195M-$220M

07:28 EDT Guardian Capital announces fund mergers - Guardian Capital announced that three exchange-traded funds managed by the Manager will be merged into a corresponding mutual fund with an identical mandate. Each Continuing Fund is an investment fund managed by the Manager. Upon completion of the mergers, securityholders will no longer hold ETF series securities of the applicable Terminating Fund. Instead, securityholders will hold ETF series securities of the applicable Continuing Fund. The mergers are part of the Manager's ongoing initiative to streamline and modernize its fund lineup and will result in Continuing Funds that offer both mutual fund and ETF series of units. In connection with the mergers, the Manager intends to qualify Unhedged ETF series units and Hedged ETF series units of each of Guardian Directed Equity Path Portfolio and Guardian Directed Premium Yield Portfolio, and ETF series units of Guardian Canadian Bond Fund.

07:27 EDT Genius Group spin off of ERL approved by Singapore Court - Genius Group announces that the Singapore Court has approved the spin off of Entrepreneur Resorts Limited, ERL. The Court Hearing took place in Singapore on Tuesday, August 1st at 10am SGT. Details about the spin off of ERL such as the timeline, record date, and share distribution date will be provided to shareholders once the process is finalized.

07:26 EDT ZeroFox appoints new members to its board of directors - ZeroFox announced that three new members were elected to its Board of Directors, effective June 29, 2023. Paul Hooper, former Chief Executive Officer and current member of the board of directors of Gigamon Inc; Barbara Stewart, former CEO of AmeriCorps and current Trustee & Executive Director of the Bowe Stewart Foundation; Teresa Shea, former Vice President at Raytheon and Senior Executive at the National Security Agency

07:25 EDT Shift4 Payments boosts FY23 end-to-end payment volume view to $108B-$114B - Shift4 Payments increases FY23 end-to-end payment volume view to $108B-$114B.

07:24 EDT Huntington Ingalls sees 2023 shipbuilding revenue $8.4M-$8.6B - Reaffirming shipbuilding and Mission Technologies 2023 guidance: Expect FY23 shipbuilding revenue between $8.4 and $8.6 billion; expect shipbuilding operating margin between 7.7% and 8.0%; Expect FY23 Mission Technologies revenue of approximately $2.5 billion; Expect Mission Technologies segment operating margin between 2.5% and 3.0%, and Mission Technologies EBITDA margin between 8.0% and 8.5%; Reaffirming free cash flow guidance; Expect FY23 free cash flow2 between $400 and $450 million; Expect cumulative FY20-FY24 free cash flow of approximately $2.9 billion; Revising operating FAS/CAS adjustment, non-current state income tax and interest expense guidance

07:21 EDT BioCryst sees 2023 global net ORLADEYO revenue no less than $320M - The company expects full year 2023 global net ORLADEYO revenue to be no less than $320 million. Operating expenses for full year 2023, not including non-cash stock compensation, are expected to be flat to 2022 at approximately $375 million. While flat year-over-year, we expect reductions in R&D spending in 2023 following the discontinuation of the BCX9930 and BCX9250 programs in 2022 and the delay in the BCX10013 clinical program, offset by increases in SG&A to support the U.S. launch and global expansion of ORLADEYO.

07:16 EDT Perella Weinberg Partners CFO Gary Barancik to step down on December 31 - With this morning's results, PWP announced that, effective December 31, 2023, Gary Barancik will be stepping down from his role as CFO. Barancik joined PWP as an Advisory Partner at its founding in 2006, became its CFO in 2018, and has led the finance organization through PWP's transition to a public company. Alexandra Gottschalk, who has been with the firm for over 12 years, including five years as its Chief Accounting Officer, will become CFO effective January 1, 2024.

07:14 EDT Wesco reports preliminary workday adjusted July sales up 3% y/y - Comments taken from Q2 earnings conference call presentation slides.

07:13 EDT ProQR Therapeutics announces anticipated upcoming events - Present various platform updates over the next several quarters, including liver NHP data, at scientific conferences, as well as research related to ongoing discovery efforts and pipeline programs. Continue to execute on existing partnership with Eli Lilly. ProQR may selectively form new partnerships, which could include multi-target discovery alliances, similar to the Company's partnership with Lilly, or product alliances on specific programs. ProQR is on track to advance AX-0810 targeting NTCP and AX-1412 targeting B4GALT1 into clinical development in late 2024/early 2025.

07:11 EDT Compass Pathways sees 2023 net cash use $80M-$90M - Third quarter 2023 net cash used in operating activities is expected to be in the range of ($2 million) to $18 million. This range includes the amount receivable in respect of the R&D tax credit in the UK, the timing for which is uncertain. We expect the full-year 2023 net cash used in operating activities to be in the range of $80 million to $90 million.

07:10 EDT Voyager Therapeutics expects cash to fund operations into 2025 - The company said, "Voyager is committed to maintaining a strong balance sheet that supports the advancement and growth of its platform and pipeline. Voyager continues to assess its planned cash needs both during and in future periods. As communicated previously, we expect our cash, cash equivalents, and marketable securities, along with amounts expected to be received as reimbursement for development costs under the Neurocrine collaborations and interest income, to be sufficient to meet Voyager's planned operating expenses and capital expenditure requirements into 2025."

07:09 EDT ConocoPhillips sees Q2 production 1.78M-1.82M MMBOED per day - Third-quarter 2023 production is expected to be 1.78 to 1.82 million barrels of oil equivalent per day MMBOED. Full-year production is now expected to be 1.80 to 1.81 MMBOED, as compared to prior guidance of 1.78 to 1.80 MMBOED. Consistent with raising full-year production guidance for two consecutive quarters, the company updated its 2023 adjusted operating cost guidance to $8.3 billion versus the prior guidance of $8.2B and updated full-year guidance for depreciation, depletion and amortization to $8.2 billion versus the prior guidance of $8.1 billion. Full-year guidance for adjusted corporate segment net loss has been lowered to $0.8 B from $0.9 Bdriven by lower net interest expense. On capital, the guidance range has been narrowed to $10.8 to $11.2 B from $10.7 to $11.3B reflecting ongoing progress on the company's development plans. All guidance excludes any impact from the previously announced Surmont and APLNG transactions.

07:05 EDT Kymera Therapeutics announces anticipated upcoming milestones - Kymera's partner Sanofi plans to initiate Phase 2 clinical trials of IRAK4 degrader KT-474 in both HS and AD in the fourth quarter of 2023. Kymera plans to share updates on its clinical-stage oncology programs later this year, including data evaluating anti-tumor activity in the target patient populations for KT-333 and KT-413 and initial safety and proof-of-mechanism data from the KT-253 Phase 1 clinical trial.

06:35 EDT Lionsgate to acquire eOne from Hasbro for $500M - Lionsgate (LGF.A) and Hasbro (HAS) announced that they have signed an agreement under which Lionsgate will acquire the independent content platform eOne in a transaction valued at approximately $500 million, comprised of cash of $375M subject to additional purchase price adjustments, and the assumption of production financing loans. The agreement is subject to Hart-Scott-Rodino approval and customary closing conditions. Under the agreement, Lionsgate will acquire a library that includes titles such as 1917, Atomic Blonde, Green Book, Grey's Anatomy, Criminal Minds, Renegade and Designated Survivor. eOne's scripted television business is powered by The Rookie TV franchise, now in its sixth season on ABC, the spinoff The Rookie: Feds, and production of Showtime's critically-acclaimed horror thriller Yellowjackets. eOne's unscripted business is led by the long-running reality series Naked & Afraid.

06:22 EDT Nintendo reports Q1 hardware units sold 3.91M, up 13.9% y-o-y - The company said, "Regarding the Nintendo Switch business during the first quarter, The Legend of Zelda: Tears of the Kingdom got off to a good start recording sales of 18.51 million units. The April release of The Super Mario Bros. Movie positively impacted sales of Mario related titles, with Mario Kart 8 Deluxe recording sales of 1.67 million units. Other titles also continued to sell steadily. As a result of these factors, hardware unit sales increased 13.9% year-on-year to 3.91 million units, and software unit sales increased 26.1% year-on-year to 52.21 million units. Turning to the digital business for our dedicated video game platform, digital sales rose 35.9% year-on-year to 119.6 billion yen, helped by the depreciation of the yen combined with good sales of downloadable versions of packaged software for Nintendo Switch and increased sales related to Nintendo Switch Online. In the mobile and IP related business, the combination of an increase in income from royalties and the high level of audience engagement with The Super Mario Bros. Movie resulted in overall sales of 31.8 billion yen. The end result is that overall sales reached 461.3 billion yen, with sales outside Japan of 369.0 billion yen accounting for 80.0% of that total. Operating profit came to 185.4 billion yen. With the depreciation of the yen in foreign exchange markets, we recorded foreign exchange gains of 47.2 billion yen, with the result that ordinary profit totaled 253.7 billion yen and profit attributable to owners of parent totaled 181.0 billion yen."

06:03 EDT Fennec appoints Adrian Haigh as COO - Fennec (FENC) has expanded its leadership team with the appointment of Adrian Haigh as COO. Adrian has been a board member of Fennec since 2014 and with his appointment to the management team of Fennec will step down as board member. Adrian recently retired from PTC Therapeutics (PTCT) where his last role was senior VP and head of international.

05:35 EDT Roche expands business partnership agreement with Sysmex - Roche announced the expansion of its global business partnership agreement with Sysmex. As part of the renewed framework, the companies strengthen their commitment to their long-standing partnership. Roche has been collaborating with Sysmex for 25 years and through the renewed terms, Roche will continue to offer Sysmex' hematology products, complementing their total lab solutions portfolio. The updated non-exclusive agreement also introduces a new area of collaboration with an additional eco-social agreement to jointly explore more sustainable diagnostic solutions. By taking their long-standing collaboration beyond the current portfolio, both companies are committed to pursue more sustainable solutions.

05:12 EDT Fusion Fuel enters green hydrogen offtake contract with Spanish customer - Fusion Fuel announced that it has entered into a long-term green hydrogen offtake contract with a Spanish industrial group. The hydrogen is to be produced at a 2.5 MW green hydrogen project in Toledo, Spain that Fusion Fuel plans to develop in 2024. Earlier this year the project was awarded EUR 3.3M in grant funding from Spain's H2 Pioneros program. The long-term supply agreement, which provides for the supply of 111.5 tons of green hydrogen per annum, marks yet another important milestone in the pre-FID development of the project. It also represents Fusion Fuel's first green hydrogen offtake contract in Spain and, critically, a tangible commitment from one of Spain's most prominent companies to make decarbonization a strategic priority.